Investors
Egetis is an innovative, unique, and integrated pharmaceutical drug development company, focusing on projects in late-stage development for treatment of serious rare/niche diseases with significant unmet medical needs in the orphan drug segment
Link to the insider trading information on Finansinspektionen.
November 26, 2024
DNB Nordic Healthcare Conference (Oslo)
December 3, 2024
Redeye Technology & Life Science Day (Stockholm & online)
Share
Address: Klara Norra Kyrkogata 26, SE 111 22 Stockholm, Sweden
Phone: +46 8 679 72 10
E-mail: [email protected]
